Design of a multicentered randomized controlled trial on the clinical and cost effectiveness of schema therapy for personality disorders

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Bamelis, Lotte Lm ^a   Evers, Silvia Maa ^a   Arntz, Arnoud ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Netherlands Institute for Advanced Study in the Humanities and Social Sciences NIAS KNAW   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; PERSONALITY DISORDER; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; COST-BENEFIT ANALYSIS; HUMANS; MIDDLE AGED; NETHERLANDS; PERSONALITY DISORDERS; PSYCHOTHERAPY; RESEARCH DESIGN; YOUNG ADULT;

EID: 84856071041     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-75     Document Type: Article

References (86)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. Fourth edition, text revision Washington DC: American Psychiatric Association 2005
2. Psychodynamic psychotherapy for personality disorders. Oldham JM, American Journal of Psychiatry 2007 164 10 1465 1467 10.1176/appi.ajp.2007. 07071174 17898332 (Pubitemid 350069720)
3. Personality disorder: a new global perspective. Tyrer P, Mulder R, Crawford M, Newton-Howes G, Simonsen E, Ndetei D, Koldobsky N, Fossati A, Mbatia J, Barrett B, World Psychiatry 2010 9 56 60 20148162
4. Persoonlijkheidsstoornissen in een instelling voor tweedelijns geestelijke gezondheidszorg Prevalentie, kenmerken, behandelindicatie en drop-out. Ten Kate CA, Eurelings-Bontekoe EH, Muller N, Spinhoven P, tijdschrift voor Psychiatrie 2007 49 9 597 609 17853369 (Pubitemid 47447549)
5. Prevalence of personality disorder in the case-load of an inner-city assertive outreach team. Ranger M, Methuen C, Rutter D, Rao B, Tyrer P, Psychiatric Bulletin 2004 28 441 443 10.1192/pb.28.12.441 (Pubitemid 39646573)
6. DSM-IV personality disorders in the WHO world mental health surveys. Huang Y, Kotov R, de Girolamo G, Preti A, Angermeyer M, Benjet C, Demyttenaere K, de Graaf R, Gureje O, Karam AN, et al. British Journal of Psychiatry 2009 195 46 53 10.1192/bjp.bp.108.058552 19567896
7. The interpersonal problems of the socially avoidant: self and peer shared variance. Rodebaugh TL, Gianoli MO, Turkheimer E, Oltmanns TF, Journal of Abnormal Psychology 2010 119 2 331 340 20455606
8. Social functioning of patients with personality disorder in secondary care. Newton-Howes G, Tyrer P, Weaver T, Psychiatric Services 2008 59 9 1033 1037 10.1176/appi.ps.59.9.1033 18757597
9. The impact of avoidant personality disorder on psychosocial impairment is substantial. Wilberg T, Karterud S, Pedersen G, Urnes O, Nordic Journal of Psychiatry 2009 63 5 390 396 10.1080/08039480902831322
10. The Collaborative Longitudinal Personality Disorders Study (CLPS): Overview and Implications. Skodol AE, Gunderson JG, Shea MT, McGlashan HT, Morey LC, Sanislow CA, Bender DS, Grilo CM, Zanarini MC, Yen S, et al. Journal of Personality Disorders 2005 19 5 487 504 10.1521/pedi.2005.19.5.487 16274278 (Pubitemid 41618523)
11. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Skodol AE, Gunderson JG, McGlashan TH, Dyck IR, Stout RL, Bender DS, Grilo CM, Shea MT, Zanarini MC, Morey LC, et al. American Journal of Psychiatry 2002 159 2 276 283 10.1176/appi.ajp.159.2.276 11823271 (Pubitemid 34126906)
12. Co-occurrence of avoidant personality disorder and child sexual abuse predicts poor outcome in long-standing eating disorder. Vrabel KR, Hoffart A, Ro O, Martinsen EW, Rosenvinge JH, Journal of Abnormal Psychology 2010 119 3 623 629 20677852
13. Predictors of mental disorders and their outcome in a community based cohort. Beard JR, Heathcote K, Brooks R, Earnest A, Kelly B, Social Psychiatry and Psychiatric Epidemiology 2007 42 623 630 10.1007/s00127-007-0182-3 17589800 (Pubitemid 47190037)
14. Personality disorder and the outcome of depression: meta-analyses of published studies. Newton-Howes G, Tyrer P, Johnson T, British Journal of Psychiatry 2006 188 13 20 10.1192/bjp.188.1.13 16388064 (Pubitemid 43021921)
15. Avoidant personality disorder symptoms in first-degree relatives of schizophrenia patients predict performance on neurocognitive measures: the UCLA family study. Fogelson DL, Asarnow RA, Sugar CA, Subotnik KL, Jacobson KC, Neale MC, Kendler KS, Kuppinger H, Nuechterlein KH, Schizophrenia Research 2010 120 113 120 10.1016/j.schres.2009.12.004 20053537
16. Personality disorder traits as predictors of subsequent first-onset panic disorder or agoraphobia. Bienvenu OJ, Stein MB, Samuels JF, Onyike CU, Eaton WW, Nestadt G, Comprehensive Psychiatry 2008 50 3 209 214 19374963
17. Stability and change in personality pathology: revelations of three longitudinal studies. Clark LA, Journal of Personality Disorders 2005 19 5 524 532 10.1521/pedi.2005.19.5.524 16274280 (Pubitemid 41618525)
18. Treatment Utilization by Patients With Personality Disorders. Bender DS, Dolan RT, Skodol AE, Sanislow CA, Dyck IR, McGlashan TH, Shea MT, Zanarini MC, Oldham JM, Gunderson JG, American Journal of Psychiatry 2001 158 2 295 302 10.1176/appi.ajp.158.2.295 11156814 (Pubitemid 32116528)
19. The economic burden of personality disorders in mental health care. Soeteman DI, Hakkaart-van Roijen L, Verheul R, Busschbach JJV, Journal of Clinical Psychiatry 2008 69 2 259 265 10.4088/JCP.v69n0212 18363454 (Pubitemid 351469269)
20. Effektivitäts zur Schematherapie. Bamelis L, Giesen-Bloo J, Bernstein DP, Arntz A, Fortschritte der Schematherapie Göttingen: Hogrefe, Roediger E, Jacob GA, 2010
21. The efficacy of various modalities of psychotherapy for personality disorders: a systematic review of the evidence and clinical recommendations. Verheul R, Herbrink M, International Review of Psychiatry 2007 19 1 25 38 10.1080/09540260601095399 17365156 (Pubitemid 46439707)
22. Follow-up psychotherapy outcome of patients with dependent, avoidant and obsessive-compulsive personality disorders: a meta-analytic review. Simon W, International Journal of Psychiatry in Clinical Practice 2009 13 2 153 165 10.1080/13651500802570972
23. Comparison of brief dynamic and cognitive-behavioural therapies in avoidant personality disorder. Emmelkamp PMG, Benner A, Kuipers A, Feiertag GA, Koster HC, Apeldoorn van FJ, British Journal of Psychiatry 2006 189 60 64 10.1192/bjp.bp.105.012153 16816307 (Pubitemid 44023331)
24. Randomized, Controlled Trial on the Effectiveness of Short-Term Dynamic Psychotherapy and Cognitive Therapy for Cluster C Personality Disorders. Svartberg MD, Stiles TC, Seltzer MH, American Journal of Psychiatry 2004 161 5 810 817 10.1176/appi.ajp.161.5.810 15121645 (Pubitemid 38625333)
25. Manualized supportive-expressive psychotherapy versus nonmanualized community-delivered psychodynamic therapy for patients with personality disorders: bridging efficacy and effectiveness. Vinnars B, Barber JP, Norén K, Gallop R, Weinryb RM, American Journal of Psychiatry 2005 162 10 1933 1940 10.1176/appi.ajp.162.10.1933 16199841 (Pubitemid 41428624)
26. Psychotherapy for personality disorders: short-term day hospital psychotherapy versus outpatient individual therapy-a randomized controlled study. Arnevik E, Wilberg T, Urnes O, Johansen M, Monsen JT, Karterud S, European Psychiatry 2009 24 71 78 10.1016/j.eurpsy.2008.09.004 19097870
27. Outpatient group psychotherapy following day treatment for patients with personality disorders. Wilberg T, Karterud S, Pedersen G, Urnes O, Irion T, Brabrand J, Haavaldsen G, Leirvag H, Johnsen K, Andreasen H, et al. Journal of Personality Disorders 2003 17 6 510 521 10.1521/pedi.17.6.510.25357 14744077 (Pubitemid 38084406)
28. Effectiveness of different modalities of psychotherapeutic treatment for patients with Cluster C personality disorders: results of a large prospective multicenter study. Bartak A, Spreeuwenberg MD, Andrea H, Holleman L, Rijnierse P, van Rossum B, Hamers EFM, Meerman AMMA, Aerts J, Busschbach JJV, et al. Psychotherapy and Psychosomatics 2010 79 20 30 10.1159/000254902 19887888
29. Efficacy of combined therapy and pharmacotherapy for depressed patients with or without personality disorders. Kool S, Dekker J, Duijsens I, de Jonghe F, Puite B, Harvard Review of Psychiatry 2003 11 3 133 141 10.1080/ 10673220303950 12893503 (Pubitemid 36765071)
30. Cognitive therapy versus moclobemide in social phobia: a controlled study. Oosterbaan DB, van Balkom AJLM, Spinhoven P, van Oppen P, Van Dyck R, Clinical Psychology and Psychotherapy 2001 8 263 273 10.1002/cpp.291 (Pubitemid 33696285)
31. Prevalence and treatment of narcissistic personality disorder in the community: a systematic review. Dhawan N, Kunik ME, Oldham JM, Coverdale J, Comprehensive Psychiatry 2010
32. A time series evaluation of the treatment of histrionic personality disorder with cognitive analytic therapy. Kellett S, Psychology and Psychotherapy: Theory, Research and Practice 2007 80 389 405 10.1348/147608306X161421 (Pubitemid 47547200)
33. Advances in psychotherapy of personality disorders: a research update. McMain S, Pos AE, Current Psychiatry Reports 2007 9 46 52 10.1007/s11920-007- 0009-7 17257514 (Pubitemid 46243104)
34. Promising psychotherapies for personality disorders. Hadjipavlou F, Ogrodniczuk JS, The Canadian Journal of Psychiatry 2010 55 4 202 210
35. Cost-effectiveness of psychotherapy for cluster B personality disorders. Soeteman DI, Verheul R, Delimon J, Meerman AMMA, van den Eijnden E, Van Rossum B, Ziegler U, Thunnissen M, Busschbach JJV, Kim JJ, British Journal of Psychiatry 2010 196 396 403 10.1192/bjp.bp.109.070482 20435967
36. Cost-effectiveness of psychotherapy for cluster C personality disorders: a decision-analytic model in the Netherlands. Soeteman DI, Verheul R, Meerman AMMA, Ziegler U, Van Rossum B, Delimon J, Rijnierse P, Thunnissen M, Busschbach JJV, Kim JJ, Journal of Clinical Psychiatry 2011 72 1 51 59 10.4088/JCP. 09m05228blu 21034679
37. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Giesen-Bloo J, van Dyck R, Spinhoven P, van Tilburg W, Dirksen C, van Asselt T, Kremers I, Nadort M, Arntz A, Archives of General Psychiatry 2006 63 649 658 10.1001/archpsyc.63.6.649 16754838 (Pubitemid 43848296)
38. Implementation of Outpatient Schema therapy for Borderline Personality Disorder with versus without crisis support by the therapist outside office hours: a randomized trial. Nadort M, Arntz A, Smit JH, Wensing M, Giesen-Bloo J, Eikelenboom M, Spinhoven P, van Dyck R, Behaviour Research and Therapy 2009 47 11 961 973 10.1016/j.brat.2009.07.013 19698939
39. A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial. Farrell J, Shaw I, Webber M, Journal of Behavior Therapy and Experimental Psychiatry 2009
40. Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy. van Asselt ADI, Dirksen C, Arntz A, Giesen-Bloo J, Van Dyck R, Spinhoven P, van Tilburg W, Kremers IP, Nadort M, Severens JL, British Journal of Psychiatry 2008 192 6 450 457 10.1192/bjp.bp.106.033597 18515897 (Pubitemid 351809899)
41. The use of psychological treatments for people with personality disorder: a systematic review of randomized controlled trials. Duggan C, Huband N, Smailagic N, Ferriter M, Adams C, Personality and Mental Health 2007 1 95 125 10.1002/pmh.22
42. Effectiveness of treatment of childhood memories in cognitive therapy for personality disorders: A controlled study contrasting methods focusing on the present and methods focusing on childhood memories. Weertman A, Arntz A, Behaviour Research and Therapy 2007 45 2133 2143 10.1016/j.brat.2007.02.013 17462588 (Pubitemid 47210951)
43. Psychologische psychotherapie der persönlichkeitsstöringen Göttingen: Hogrefe-Verlag, Sachse R, 2001
44. Structured Clinical Interview for DSM-IV Axis I disorders (SCID I) New York: Biometric Research Department, First MB, Spitzer RL, Gibbon M, Williams J, 1997
45. First MB, Spitzer RL, Gibbon M, Williams J, Benjamin L, Structured clinical interview for DSM-IV Axis II personality disorders (SCID II) New York: Biometric Research Department 1994
46. van Groenestijn MAC, Akkerhuis GW, Kupka RW, Schneider N, Nolen WA, Gestructureerd klinisch interview voor de vaststelling van DSM-IV as I stoornissen (SCID I) (Structural clinical interview for DSM-IV Axis I disorders (SCID I) Lisse: Swets & Zeitlinger 1999
47. Weertman A, Arntz A, Kerkhofs MLM, Gestructureerd diagnostisch interview voor DSM-IV persoonlijkheidsstoornissen (SCID II). (Structural clinical interview for DSM IV personality disorders (SCID II) Lisse: Swets Test Publisher 2000
48. Effectiveness of Psychotherapy for Personality Disorders. Perry JC, Banon E, Ianni F, American Journal of Psychiatry 1999 156 9 1312 1321 10484939 (Pubitemid 29416525)
49. Adaptive biased urn randomization in small strata when blinding is impossible. Schouten HJA, Biometrics 1995 51 1529 1535 10.2307/2533283 8589238 (Pubitemid 26030197)
50. Young JE, Klosko JS, Weishaar ME, Schema Therapy: a practitioner's guide New York: The Guilford 2003 21928283
51. Arntz A, Jacob GA, Bernstein DP, Schema therapy in practice: an introductory guide to the schema mode approach; in preparation
52. Schema therapy for cluster C personality disorders. Arntz A, The Wiley-Blackwell handbook of schema therapy: theory, research and practice (the "work") Chichester: Wiley-Blackwell, Van Vreeswijk M, Broersen J, Nadort M
53. Schema Mode Inventory 2. Internal Document. Arntz A, Young JE, Maastricht 2006
54. From client-centered psychotherapy to clarification-oriented psychotherapy. Sachse R, Person-centered and Experiental Psychotherapies 2004 3 1 19 35 10.1080/14779757.2004.9688327
55. Landelijke Stuurgroep Richtlijnontwikkeling in de GGZ, Multidisciplinaire richtlijn persoonlijkheidsstoornissen (Multidisciplinary Clinical Guideline of Personality Disorders) Utrecht 2008
56. Young J, Arntz A, Giesen-Bloo J, Therapy adherence and competence scale for schema focused therapy New York/Maastricht: Authors 1999
57. Development of a system for rating therapies for depression: differentiating cognitive therapy, interpersonal psychotherapy, and clinical management pharmacotherapy. Hollon SD, Evans MD, Auerbach A, DeRubeis RJ, Elkin I, Lowery A, Kriss M, Grove W, Tuason VB, Piasecki J, 1988 Unpublished manuscript
58. Systems for rating therapies for depression. Hollon SD, Waskow IE, Evans M, Lowery A, Annual convention of the American Psychiatric Association Los Angeles, CA 1984
59. Euroqol - a new facility for the measurement of health-related quality of life. EuroQol Group, Health Policy 1990 16 199 208 10109801
60. EuroQol: the current state of play. Brooks R, Health Policy 1996 37 53 72 10.1016/0168-8510(96)00822-6 10158943 (Pubitemid 26191458)
61. Inter-rater reliability of the structured clinical interview for DSM-IV Axis I disorders (SCID I) and Axis II disorders (SCID II). Lobbestael J, Leurgans M, Arntz A, Clinical Child Psychology and Psychiatry 2011 18 75 79
62. Interrater reliability and internal consistency fo the Structured Clinical Interview for DSM-IV Axis II personality disorders (SCID-II), version 2.0. Maffei C, Fossati A, Agostini I, Barraco A, Bagnato M, Deborah D, Namia C, Novella L, Petrachi M, Journal of Personality Disorders 1997 11 3 279 284 10.1521/pedi.1997.11.3.279 9348491 (Pubitemid 27478022)
63. Short-interval test-retest interrater reliability of the Dutch version of the Structured Clinical Interview for DSM-IV Personality Disorders (SCID II). Weertman A, Arntz A, Dreessen L, van Velzen C, Vertommen S, Journal of Personality Disorders 2003 17 6 562 567 10.1521/pedi.17.6.562.25359 14744081 (Pubitemid 38084410)
64. Schotte C, de Doncker D, ADP-IV Questionnaire: Manual and norms Antwerp: University Hospital Antwerp 1996
65. Self-report assessment of the DSM-IV personality disorders. Measurement of trait and distress characteristics: the ADP-IV. Schotte CKW, de Doncker D, Vankerckhoven C, Vertommen H, Cosyns P, Psychological Medicine 1998 28 1179 1188 10.1017/S0033291798007041 9794025 (Pubitemid 28458474)
66. Validation of the German version of the Assessment of DSM-IV Personality Disorders (ADP-IV) Questionnaire. Doering S, Renn D, Höfer S, Rumpold G, Smrekar U, Janecke N, Schatz DS, Schotte C, Schüsler G, Zeitschrift für Psychosomatische Medizin und Psychotherapie 2007 53 2 111 128 19349661 (Pubitemid 47014114)
67. The ADP-IV Questionnaire: differential validity and concordance with the semi-structured interview. Schotte C, De Doncker D, Dmitruk D, Mulders van I, D'Haenen H, Cosyns P, Journal of Personality Disorders 2004 18 405 419 15342327 (Pubitemid 39313811)
68. Reliability and validity of DSM-IV Axis V. Hilsenroth MJ, Ackerman SJ, Blagys MD, Baumann BD, Baity MR, Smith SR, Price JL, Smith CL, Heindselman TL, Mount MK, et al. American Journal of Psychiatry 2000 157 11 1858 1863 10.1176/appi.ajp.157.11.1858 11058486
69. The concurrent validity of the global assessment of functioning (GAF). Startup M, Jackson MC, Bendix S, British Journal of Clinical Psychology 2002 41 417 422 10.1348/014466502760387533 12437796 (Pubitemid 35439333)
70. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Derogatis LR, Rickels K, Rock AF, British Journal of Psychiatry 1976 128 280 289 10.1192/bjp.128.3.280 1252693
71. Dimensional structure, reliability and validity of the Dutch version of the Symptom Checklist (SCL-90): data based on a phobic and a "normal" population. Arrindell WA, Ettema H, Nederlands Tijdschrift voor de Psychologie 1981 36 2 77 108
72. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Mundt JC, Marks IM, Shear MK, Greist JH, British Journal of Psychiatry 2002 180 461 464 10.1192/bjp.180.5.461 11983645 (Pubitemid 34499343)
73. Reliability and validity of the Work and Social Adjustment Scale in phobic disorders. Mataix-Cols D, Cowley AJ, Hankins M, Schneider A, Bachofen M, Kenwright M, Gega L, Cameron R, Marks IM, Comprehensive Psychiatry 2005 46 223 228 10.1016/j.comppsych.2004.08.007 16021593 (Pubitemid 40545938)
74. Self-concept and psychiatric symptomatology. Miskimins RW, Wilson LT, Braucht GN, Berry KL, Journal of Clinical Psychology 1971 27 2 185 187 10.1002/1097-4679(197104)27:2<185::AID-JCLP2270270207>3.0.CO;2-U 5542462
75. Word use of outpatients with a personality disorder and concurrent or previous major depressive disorder. Molendijk ML, Bamelis L, van Emmerik AAP, Arntz A, Haringsma R, Spinhoven P, Behaviour Research and Therapy 2010 48 1 44 51 10.1016/j.brat.2009.09.007 19819423
76. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. WhoQol Group, Psychological Medicine 1998 28 551 558 9626712
77. The World Health Organization Quality of Life Assessment (Whoqol): development and general psychometric properties. WhoQol Group, Social Science & Medicine 1998 46 12 1569 1585 10.1016/S0277-9536(98)00009-4 22282574 (Pubitemid 28288690)
78. Modeling valuations for EuroQol health states. Dolan P, Medical Care 1997 35 11 1095 1108 10.1097/00005650-199711000-00002 9366889 (Pubitemid 127453463)
79. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. Goossens MEJB, Rutten-van Mölken MPMH, Vlaeyen JWS, van der Linden SMJP, Journal of Clinical Epidemiology 2000 53 688 695 10.1016/S0895-4356(99)00177-8 10941945 (Pubitemid 30609621)
80. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, Rutten FFH, Handleiding voor kostenonderzoek: methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg (Geactualiseerde versie 2004) (Dutch manual for costing: methods and standard costs for economic evaluations in health care (actualized version 2004) Diemen: College voor Zorgverzekeringen 2004
81. College voor Zorgverzekeringen, Farmacotherapeutisch kompas 2008 (Pharmacotherapeutic Compass 2008) Diemen: College voor Zorgverzekeringen 2007
82. Difficulties in Calculating Productivity Costs: Work Disability Associated with Borderline Personality Disorder. Asselt ADI, Dirksen CD, Arntz A, Severens JL, International Society for Pharmacoeconomics and Outcome Research 2007
83. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Lamers LM, McDonnell J, Stalmeier PFM, Krabbe PFM, Busschbach JJV, Health Economics 2006 15 1121 1132 10.1002/hec.1124 16786549 (Pubitemid 44596379)
84. Zinnige en duurzame zorg (Sensible and sustainable care). Raad voor de Volksgezondheid en Zorg, Zoetermeer 2006
85. Can assessors and therapists predict the outcome of long-term psychotherapy in borderline personality disorder? Spinhoven P, Giesen-Bloo J, van Dyck R, Arntz A, Journal of Clinical Psychology 2008 64 6 667 686 10.1002/jclp.20466 18384120 (Pubitemid 351897274)
86. Gold M, Siegel J, Russell L, Weinstein M, Cost-effectiveness in health and medicine New York: Oxford University 1996